A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry-Reference-Cited by-同舟云学术

A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

Published:2022-08-12 Issue:12 Volume:23 Page:1457-1465
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Esteve-Pastor María Asunción¹^ORCID,Rivera-Caravaca José Miguel¹^ORCID,Ruiz-Ortiz Martín²,Muñiz Javier³,Roldán-Rabadán Inmaculada⁴,Otero Déborah⁵,López-Gálvez Raquel¹,Cequier Ángel⁶,Bertomeu-Martínez Vicente⁷,Badimón Lina⁸,Anguita Manuel²,Lip Gregory Y.H.⁹¹⁰,Marín Francisco¹^ORCID

Affiliation:

1. Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain

2. Department of Cardiology, Hospital Universitario Reina Sofía, Maimonides Institute for Biomedical Research of Cordoba, IMIBIC, Córdoba, Spain

3. Departamento de Ciencias de la Salud e Instituto de Investigación Biomédica de A Coruña (INIBIC), La Coruña, CIBERCV, Universidade da Coruña, Grupo de Investigación Cardiovascular, Coruña, Spain

4. Department of Cardiology, Hospital La Paz, Madrid, Spain

5. ODDS, SL, A Coruña, Coruña, Spain

6. Department of Cardiology, Hospital de Bellvitge, CIBERCV, Barcelona, Spain

7. Department of Cardiology, Hospital Universitario de San Juan, Alicante, Spain

8. Cardiovascular Research Center (CSIC-ICCC), Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, CIBERCV, Catalonia, Spain

9. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK

10. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Funder

Instituto de Salud Carlos III (Madrid)-FEDER

Instituto Murciano de Investigación Biosanitaria

Spanish Ministry of Economy, Industry, and Competitiveness, through the Instituto de Salud Carlos III

European Regional Development Fund

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2109961

Reference36 articles.

1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

3. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

4. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative pharmacology of direct oral anticoagulants and vitamin K antagonist;2022-11-12

2. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries;Journal of Comparative Effectiveness Research;2022-11